W06--Food for Thought: Best of Nutrition Research

Thursday, October 23, 2025

10:15 AM - 12:15 PM PDT

Location:Signature Room

Chair(s)

Terri Schindler, MS, RDN, CACFD

University Hospitals
Laura Padula, MS, RD, LDN

Children's Hospital of Philadelphia

Nutrition plays a vital role in the management and long-term outcomes of individuals with cystic fibrosis. In this workshop session, we will highlight cutting-edge studies that are shaping the future of nutritional care in CF. This session will spotlight a range of emerging topics related to colorectal cancer screening, body composition, and the role of HEMT on the gastrointestinal tract.

Learning Objectives:

Understand the role of body composition and diet in the nutrition and medical management of CF
List appropriate testing to monitor colorectal cancer in CF
Review impact of highly effective modulator therapy on the GI system

Presentations:

10:15 AM - 12:15 PM PDT

W06.1- Impact of Elexacaftor/Tezacaftor/Ivacaftor therapy on gastrointestinal inflammation, motility, and symptoms in Cystic Fibrosis: A multicenter prospective study
Speaker: Liron Birimberg-Schwartz, n/a – Hadassah Medical Center and the Faculty of Medicine
10:15 AM - 12:15 PM PDT

W06.2- Correlations between skeletal muscle mass, BMI z-score, and exercise capacity in pediatric CF using bioelectrical impedance analysis
Speaker: Amanda Leonard, MPH, RD, CDCES – Johns Hopkins Hospital
10:15 AM - 12:15 PM PDT

W06.3- A multi-center study of non-invasive colorectal cancer evaluation in Cystic Fibrosis (NICE-CF)
Speaker: Christine Hachem, MD – Saint Louis University
10:15 AM - 12:15 PM PDT

W06.4- Baseline body composition and sarcopenia measures of adults with preserved lung function in the STRONG-CF Study
Speaker: Melissa Putman, Dr. – Massachusetts General Hospita
10:15 AM - 12:15 PM PDT

W06.5- Modifiable Predictors of Beta-Cell Function in Adults with Cystic Fibrosis: The Role of Body Composition and Sugar Intake
Speaker: Tanicia C. Daley, MD, MPH – Emory University